Literature DB >> 12884422

Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy.

Matthew J Edwards1, Kingsley Agho, John Attia, Pedro Diaz, Teresa Hayes, Alice Illingworth, Laurence G Roddick.   

Abstract

A case-control survey of 48 children with nonsyndromic cleft lip or palate showed a significant increase in prevalence of maternal use of topical corticosteroid preparations in the first trimester of pregnancy, compared to 58 controls born in the same hospital; the odds ratio was 13.154, 95% confidence interval 1.67-586, P = 0.0049 on Fisher's exact two-tail test. The results were statistically significant although the wide confidence interval reflected the small sample size. Although older epidemiological studies have not detected any association between systemic corticosteroid treatment and the combined incidence of all congenital malformations, experimental studies over several decades have shown that maternal corticosteroid exposure in several species of animals is specifically associated with oral clefts. This association has been confirmed by more specific case-control surveys where the cases were children with cleft lip or palate and the exposure was maternal systemic corticosteroid treatment in the first trimester. Only one previous survey also analyzed topical corticosteroids, and it demonstrated an increased odds ratio for cleft lip or palate. A national survey of children with cleft palate will be necessary to evaluate the results of this pilot study. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884422     DOI: 10.1002/ajmg.a.20130

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway.

Authors:  Hildur Skuladottir; Allen Wilcox; Robert McConnaughey; Hallvard Vindenes; Rolv T Lie
Journal:  Ann Epidemiol       Date:  2014-07-08       Impact factor: 3.797

2.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

3.  Topical corticosteroid use during pregnancy.

Authors:  Fatoumah Alabdulrazzaq; Gideon Koren
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

4.  Fostering international collaboration in birth defects research and prevention: a perspective from the International Clearinghouse for Birth Defects Surveillance and Research.

Authors:  Lorenzo D Botto; Elisabeth Robert-Gnansia; Csaba Siffel; John Harris; Barry Borman; Pierpaolo Mastroiacovo
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

5.  Maternal food insecurity is associated with increased risk of certain birth defects.

Authors:  Suzan L Carmichael; Wei Yang; Amy Herring; Barbara Abrams; Gary M Shaw
Journal:  J Nutr       Date:  2007-09       Impact factor: 4.798

Review 6.  Management of Eosinophilic Esophagitis During Pregnancy.

Authors:  Caitlin M Burk; Millie D Long; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2016-02-18       Impact factor: 3.199

Review 7.  Pregnancy and medications in inflammatory bowel disease.

Authors:  Rena H Cao; Michael C Grimm
Journal:  Obstet Med       Date:  2020-05-11

8.  Corticosteroid use and risk of orofacial clefts.

Authors:  Hildur Skuladottir; Allen J Wilcox; Chen Ma; Edward J Lammer; Sonja A Rasmussen; Martha M Werler; Gary M Shaw; Suzan L Carmichael
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-04-29

Review 9.  Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature.

Authors:  Sofine Heilskov; Mette S Deleuran; Christian Vestergaard
Journal:  Dermatol Ther (Heidelb)       Date:  2020-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.